Zacks: Analysts Expect Baxter International Inc (NYSE:BAX) to Announce $0.84 EPS

Equities analysts expect that Baxter International Inc (NYSE:BAX) will report earnings per share (EPS) of $0.84 for the current quarter, according to Zacks Investment Research. Six analysts have made estimates for Baxter International’s earnings, with the lowest EPS estimate coming in at $0.83 and the highest estimate coming in at $0.86. Baxter International reported earnings per share of $0.80 during the same quarter last year, which would suggest a positive year-over-year growth rate of 5%. The company is scheduled to report its next quarterly earnings report on Wednesday, October 30th.

According to Zacks, analysts expect that Baxter International will report full year earnings of $3.37 per share for the current fiscal year, with EPS estimates ranging from $3.32 to $3.39. For the next year, analysts expect that the business will post earnings of $3.78 per share, with EPS estimates ranging from $3.72 to $3.92. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of sell-side research firms that that provide coverage for Baxter International.

Baxter International (NYSE:BAX) last issued its quarterly earnings results on Thursday, July 25th. The medical instruments supplier reported $0.89 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.81 by $0.08. Baxter International had a return on equity of 21.21% and a net margin of 14.28%. The firm had revenue of $2.84 billion during the quarter, compared to analysts’ expectations of $2.80 billion. During the same period in the previous year, the business earned $0.77 earnings per share. The firm’s revenue for the quarter was down .1% on a year-over-year basis.

Several equities analysts recently issued reports on BAX shares. BMO Capital Markets increased their target price on Baxter International to $95.00 and gave the stock an “outperform” rating in a research note on Friday, July 26th. Barclays set a $82.00 price objective on Baxter International and gave the company a “hold” rating in a report on Friday, July 26th. Royal Bank of Canada set a $87.00 price objective on Baxter International and gave the company a “hold” rating in a report on Friday, July 26th. Wells Fargo & Co set a $95.00 target price on Baxter International and gave the company a “buy” rating in a research report on Friday, July 26th. Finally, Piper Jaffray Companies upped their target price on Baxter International from $90.00 to $95.00 and gave the company an “overweight” rating in a research report on Thursday, July 25th. Four investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus target price of $85.27.

Shares of Baxter International stock traded down $0.38 during trading hours on Friday, hitting $84.70. The company’s stock had a trading volume of 1,573,832 shares, compared to its average volume of 2,310,100. Baxter International has a twelve month low of $61.05 and a twelve month high of $86.65. The company’s fifty day simple moving average is $82.31. The company has a market cap of $43.44 billion, a PE ratio of 27.77, a price-to-earnings-growth ratio of 1.97 and a beta of 1.00. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.30 and a current ratio of 2.78.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 1st. Stockholders of record on Friday, August 30th will be given a dividend of $0.22 per share. The ex-dividend date of this dividend is Thursday, August 29th. This represents a $0.88 annualized dividend and a dividend yield of 1.04%. Baxter International’s dividend payout ratio is presently 28.85%.

In other Baxter International news, SVP Jacqueline Kunzler sold 593 shares of the business’s stock in a transaction on Wednesday, June 19th. The shares were sold at an average price of $80.46, for a total transaction of $47,712.78. Following the sale, the senior vice president now directly owns 9,023 shares of the company’s stock, valued at approximately $725,990.58. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Third Point Llc sold 5,000,000 shares of the business’s stock in a transaction on Thursday, May 16th. The shares were sold at an average price of $76.37, for a total transaction of $381,850,000.00. The disclosure for this sale can be found here. Insiders sold 5,001,913 shares of company stock valued at $382,000,950 over the last 90 days. 0.70% of the stock is currently owned by insiders.

Large investors have recently modified their holdings of the stock. Weaver Consulting Group bought a new stake in Baxter International in the first quarter worth $25,000. C J Advisory Inc bought a new stake in shares of Baxter International in the first quarter valued at about $28,000. Personal Wealth Partners bought a new stake in shares of Baxter International in the second quarter valued at about $29,000. TRUE Private Wealth Advisors acquired a new position in Baxter International in the second quarter worth about $29,000. Finally, Evolution Wealth Advisors LLC acquired a new position in Baxter International in the second quarter worth about $32,000. Hedge funds and other institutional investors own 83.87% of the company’s stock.

About Baxter International

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies.

Featured Story: Leveraged Buyout (LBO)

Get a free copy of the Zacks research report on Baxter International (BAX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Baxter International (NYSE:BAX)

Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.